# DESCRIPTION

## FIELD

- introduce isotyping and quantification of antibodies

## BACKGROUND

- motivate need for evaluating immunogenicity
- summarize limitations of current methods

## SUMMARY

- introduce method for characterizing ADAs
- describe isotyping and quantification of ADAs
- outline method of identifying peptides or proteins
- describe contacting sample to solid support
- outline washing and isolating peptides or proteins
- describe treating isolated peptides or proteins
- outline identifying components using mass spectrometer
- describe determining isotype or subclass
- outline quantifying isolated peptides or proteins
- describe pharmaceutical products
- outline sample preparation
- describe mobile phase solutions
- outline system for identifying or quantifying peptides or proteins

## DETAILED DESCRIPTION

- motivate characterization of anti-drug antibodies (ADAs)
- describe limitations of existing methods
- introduce immunogenicity and its impacts
- explain formation of ADAs and their effects
- describe different ADA isotypes and their functions
- discuss FDA recommendations for ADA isotyping assays
- introduce immunocapture and LC-MS methods for ADA isotyping and quantification
- describe immunocapture method with acid dissociation and LC-MS analysis
- outline LC-MRM-MS method for ADA isotyping and quantification
- discuss advantages of LC-MS based method for identifying and quantifying antibody isotypes
- conclude with the development of an effective and sensitive method for identification and quantification of ADAs
- define peptide or protein
- define pharmaceutical product
- define denaturation solution
- describe protein pharmaceutical product
- define antibody fragment
- define antibody-drug conjugate
- describe antibody
- describe method of identifying and/or quantifying peptide or protein
- describe peptide mapping
- describe mass spectrometer
- describe liquid chromatography
- describe electrospray ionization
- describe triple quadrupole mass spectrometer
- describe tandem mass spectrometry
- describe protein characterization
- describe isotype or subclass of isolated peptide or protein

### Exemplary Embodiments

- introduce compositions, methods, and systems for identifying and quantifying isotypes or subclasses of antibodies
- describe method of identifying and/or quantifying at least one peptide or protein in a sample
- specify contacting sample to solid support with attached pharmaceutical product
- outline washing solid support using mobile phase solution
- describe isolating peptide or protein from eluent
- treat isolated peptide or protein with denaturation solution and/or enzymatic digestion reaction
- identify components of isolated peptide or protein using mass spectrometer
- specify treating sample with acidic solution prior to contacting solid support
- describe incubating sample with solid support at room temperature or specific temperature
- specify solid support types, such as beads or chromatography resins
- describe sample composition, including salt and surfactant
- outline washing solid support using mobile phase solution with salt and surfactant
- specify denaturation solution composition, including urea or other agents
- describe component quantification of isolated peptide or protein
- outline system for identifying or quantifying at least one peptide or protein in a sample
- specify mass spectrometer capabilities, including LC-MS or LC-MRM-MS analyses
- describe system for conducting peptide mapping and selecting unique peptides and fragment ions
- specify LLOQ and LOD/LOQ ranges for peptide or protein identification or quantification
- disclaim limitation of system to specific pharmaceutical products or mass spectrometers
- introduce ADA-Std as positive control
- compare recovery rates of ADAs using biotinylated drug-beads and cross-linked drug beads
- optimize enzymatic digestion method
- observe nonspecific interactions in serum
- optimize incubation condition for immunocapture
- optimize immunocapture by interrupting interactions in serum
- immunocapture using Fab of IgG drug
- determine low limit of quantitation (LLOQ)
- determine drug tolerance limit
- isotype and quantify ADAs in preclinical toxicology study in monkeys
- isotype and quantify ADAs in preclinical pharmacokinetic study in monkeys
- describe Example 5
- describe Example 6
- describe Example 7
- describe Example 8
- describe Example 9
- describe Example 10
- describe Example 11
- describe Example 12
- describe Example 13
- describe Example 14

